After a day of oral arguments in a packed courtroom, a Boston federal judge did not rule from the bench on a lawsuit from AAP ...

Several senior officials are exiting RFK Jr.'s department amid an effort to focus on drug pricing and food issues.

The FDA has rejected a rare disease therapy from Disc Medicine, an early recipient of a commissioner's voucher from the ...

That surveillance data was the nervous system of American medicine — constantly sensing, constantly warning us what was ...

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well ...

This week on "The Readout LOUD," everything you need to know about the FDA's controversial decision to block the review of ...

The FDA’s surprise refusal to even review Moderna’s mRNA flu vaccine is sending a chill through biotech: Companies are openly ...

Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.

Digital therapeutics developer Big Health announced Thursday that it has raised $23.7 million from notable investors betting ...

Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of vaccine development" in the U.S.

In a long-debated move, the NIH will no longer characterize basic experimental studies involving humans as clinical trials.

The AMA’s comment came in response to a recent position statement from the American Society of Plastic Surgeons that, while ...